BuMA Supreme biodegradable polymer sirolimus-eluting stent versus a durable polymer zotarolimus-eluting coronary stent: three-year clinical outcomes of the PIONEER trial

Chang, C.C. (Chun Chin), N. Kogame (Norihiro), Asano, T. (Taku), C. von Birgelen (Clemens), Sabaté, M. (Manel), Onuma, Y. (Yoshinobu) and P.W.J.C. Serruys (Patrick)

2020-12-04

EuroIntervention , Volume 16 - Issue 11 p. e900- e903

Additional Metadata
Persistent URL	doi.org/10.4244/EIJ-D-19-00566, hdl.handle.net/1765/132353
Journal	EuroIntervention
Rights	no subscription
Organisation	Department of Cardiology
Citation APA Style AAA Style APA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Chang, C.C. (Chun Chin), Kogame, N, Asano, T. (Taku), von Birgelen, C, Sabaté, M. (Manel), Onuma, Y. (Yoshinobu), & Serruys, P.W.J.C. (2020). BuMA Supreme biodegradable polymer sirolimus-eluting stent versus a durable polymer zotarolimus-eluting coronary stent: three-year clinical outcomes of the PIONEER trial. EuroIntervention, 16(11), e900–e903. doi:10.4244/EIJ-D-19-00566

Publication